Arthritis, Rheumatic and Back Disease Associates, PA — Voorhees Township, New Jersey

Arthritis, Rheumatic and Back Disease Associates, PA is a clinical research site located in Voorhees Township, New Jersey, United States 08043.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Arthritis, Rheumatic and Back Disease Associates, PA has participated in 2 clinical trials.

Therapeutic areas: Arthritis, Rheumatoid, Chronic Pain, Osteoarthritis, Hip.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Voorhees Township

Browse all research sites in New Jersey · View every site in Voorhees Township

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Arthritis, Rheumatic and Back Disease Associates, PA?

Arthritis, Rheumatic and Back Disease Associates, PA has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Arthritis, Rheumatic and Back Disease Associates, PA conducted?

Arthritis, Rheumatic and Back Disease Associates, PA has 2 clinical trials on record. Their work covers Arthritis, Rheumatoid, Chronic Pain, Osteoarthritis, Hip.

Is Arthritis, Rheumatic and Back Disease Associates, PA accredited by Crixeo Clinical Trials?

Arthritis, Rheumatic and Back Disease Associates, PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Arthritis, Rheumatic and Back Disease Associates, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.